EcoDrugPlus

Tumor Protein P53

Ensembl ID : ENSUMAG00000016933
Gene Symbol: TP53
4 Cross references
253 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSUMAG00000024078
Gene Symbol: TYR
4 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSUMAG00000006253
Gene Symbol: TH
4 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSUMAG00000025095
Gene Symbol: TYK2
4 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSUMAG00000024352
Gene Symbol: TIE1
4 Cross references
203 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSUMAG00000005907
Gene Symbol: VEGFA
3 Cross references
253 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSUMAG00000000988
Gene Symbol: VDR
4 Cross references
458 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSUMAG00000014055
Gene Symbol: VKORC1
4 Cross references
190 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSUMAG00000019926
Gene Symbol: XDH
4 Cross references
211 Possible Orthologues:

Ensembl ID : ENSUMAG00000004977
Gene Symbol: -
Cross references: -
188 Possible Orthologues:

Ensembl ID : ENSUMAG00000024386
Gene Symbol: -
Cross references: -
68 Possible Orthologues:

Ensembl ID : ENSUMAG00000010172
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).